In last week’s policy-focused Bulletin (149) we covered the publication of Transform Drug Policy Foundation’s 124-page guide, How to Regulate Psychedelics. Shortly after its publication, we spoke to co-authors Steve Rolles and Ester Kincová to better understand their perspectives on emergent international psychedelic policy ‘experiments’ and contexts.
This content is reserved for Pα+ subscribers. Head to our Join page to learn more, or sign in to your account. Explore the Library here.
Johnson & Johnson said Thursday it will pay $850 million in cash for Proteologix, a relatively unknown private biotech working on treatments for immune-mediated diseases,
When it comes to improving the lives of children with genetic conditions, medical research often focuses solely on the children. But there is an equally
UnitedHealth Group’s Optum subsidiary saw a lower operating margin in the second quarter due to more seniors getting care, a spike in demand for behavioral